Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Aging and Disease
|
February 18, 2025
Targeting Mitochondrial Integrity as a New Senolytic Strategy
Eliska Vacurova, Edita Vlachova, Jan Stursa, et al.
Frontiers in Pharmacology
|
July 10, 2024
NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
Sukanya B Jadhav, Michaela Vondrackova, Petra Potomova, et al.
World Journal of Urology
|
December 23, 2019
Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau)
Lukas Werner Prause, Lukas Manka, Christopher Millan, et al.
Cell Death Discovery
|
May 7, 2025
Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention
Klara Bohacova, Zuzana Nahacka, Jana Dudova, et al.
Cell Death and Differentiation
|
May 23, 2018
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Sona Hubackova, Eliska Davidova, Katerina Rohlenova, et al.
Oncogene
|
March 9, 2021
SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy
Zuzana Ezrova, Zuzana Nahacka, Jan Stursa, et al.
Cancer Research
|
March 9, 2021
Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy
Cristian Sandoval-Acuña, Natalia Torrealba, Veronika Tomkova, et al.
Aging and Disease
|
June 29, 2026
Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome
Michaela Rennerova, Tereza Havrlantova, Igor Simonik, et al.
Aging Cell
|
May 10, 2018
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, et al.
Therapeutic Advances in Medical Oncology
|
October 3, 2023
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
Zuzana Bielcikova, Lukas Werner, Jan Stursa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Aging and Disease
|
February 18, 2025
Targeting Mitochondrial Integrity as a New Senolytic Strategy
Eliska Vacurova, Edita Vlachova, Jan Stursa, et al.
Frontiers in Pharmacology
|
July 10, 2024
NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
Sukanya B Jadhav, Michaela Vondrackova, Petra Potomova, et al.
World Journal of Urology
|
December 23, 2019
Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau)
Lukas Werner Prause, Lukas Manka, Christopher Millan, et al.
Cell Death Discovery
|
May 7, 2025
Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention
Klara Bohacova, Zuzana Nahacka, Jana Dudova, et al.
Cell Death and Differentiation
|
May 23, 2018
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2
Sona Hubackova, Eliska Davidova, Katerina Rohlenova, et al.
Oncogene
|
March 9, 2021
SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy
Zuzana Ezrova, Zuzana Nahacka, Jan Stursa, et al.
Cancer Research
|
March 9, 2021
Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy
Cristian Sandoval-Acuña, Natalia Torrealba, Veronika Tomkova, et al.
Aging and Disease
|
June 29, 2026
Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome
Michaela Rennerova, Tereza Havrlantova, Igor Simonik, et al.
Aging Cell
|
May 10, 2018
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, et al.
Therapeutic Advances in Medical Oncology
|
October 3, 2023
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
Zuzana Bielcikova, Lukas Werner, Jan Stursa, et al.
Page
of 4